Chemed Corporation
CHE Healthcare Medical Care Facilities
Chemed Corporation’s revenue for fiscal 2025 (year ended December 2025) was $2.5 billion, up 4.06% from fiscal 2024.
- Revenue
- +10.6%
- EPS
- +23.1%
- Free cash flow
- −45.3%
Quarter to September 2026, against a year earlier
Follow CHE
Alert me
Chemed Corporation (CHE) P/S ratio
As of 5 November 2026, Chemed Corporation (CHE) trades at a P/S ratio of 2.6×. Over the past ten years it has ranged from 1.2× (January 2015) to 4.3× (March 2024); the current reading is higher than 36% of that period. That is above the Medical Care Facilities industry median of 1.0× and below the Healthcare sector median of 3.5×.
P/S ratio, daily
Embed this chart
Annual newest first
| Period | P/S ratio | Change |
|---|---|---|
| FY2025 | 2.4× | (25.63%) |
| FY2024 | 3.3× | (15.73%) |
| FY2023 | 3.9× | 9.61% |
| FY2022 | 3.5× | (8.54%) |
| FY2021 | 3.9× | (5.16%) |
| FY2020 | 4.1× | 12.93% |
| FY2019 | 3.6× | 41.79% |
| FY2018 | 2.6× | 7.25% |
| FY2017 | 2.4× | 41.28% |
| FY2016 | 1.7× | 2.86% |
Quarterly newest first
| Period | P/S ratio | Change |
|---|---|---|
| Sep 2026 | 2.5× | 4.82% |
| Jun 2026 | 2.4× | 16.28% |
| Mar 2026 | 2.0× | (16.49%) |
| Dec 2025 | 2.4× | (4.39%) |
| 43 more quarters | Free account |
Against its own ten years
P/S ratio against peers
| Company | P/S ratio |
|---|---|
| FMS Fresenius Medical Care AG & Co. KGaA compare | 0.5× |
| UHS Universal Health Services, Inc. compare | 0.6× |
| OPCH Option Care Health, Inc. compare | 0.8× |
| DVA DaVita Inc. compare | 0.9× |
| PACS PACS Group, Inc. compare | 1.4× |
| ENSG The Ensign Group, Inc. compare | 1.9× |
| CON Concentra Group Holdings Parent, Inc. compare | 2.3× |
| CHE Chemed Corporation | 2.6× |
| LFST LifeStance Health Group, Inc. compare | 3.1× |
| Medical Care Facilities industry median | 1.0× |
| Healthcare sector median | 3.5× |
| Market median | 1.9× |
What P/S ratio is
Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.
(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)
More on CHE
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement